Terms: = Ovarian cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
159 results:
1. Emilin2 fosters vascular stability by promoting pericyte recruitment.
Fejza A; Camicia L; Carobolante G; Poletto E; Paulitti A; Schinello G; Di Siena E; Cannizzaro R; Iozzo RV; Baldassarre G; Andreuzzi E; Spessotto P; Mongiat M
Matrix Biol; 2023 Sep; 122():18-32. PubMed ID: 37579864
[TBL] [Abstract] [Full Text] [Related]
2. clinical Relevance of Mortalin in ovarian cancer Patients.
Rajtak A; Czerwonka A; Pitter M; Kotarski J; Okła K
Cells; 2023 Feb; 12(5):. PubMed ID: 36899836
[No Abstract] [Full Text] [Related]
3. Elevated PAF1-RAD52 axis confers chemoresistance to human cancers.
Rauth S; Ganguly K; Atri P; Parte S; Nimmakayala RK; Varadharaj V; Nallasamy P; Vengoji R; Ogunleye AO; Lakshmanan I; Chirravuri R; Bessho M; Cox JL; Foster JM; Talmon GA; Bessho T; Ganti AK; Batra SK; Ponnusamy MP
Cell Rep; 2023 Feb; 42(2):112043. PubMed ID: 36709426
[TBL] [Abstract] [Full Text] [Related]
4. Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers.
Lan H; Yuan J; Zhang R; Jiang B; Li Q; Huang Z; Chen P; Xiang H; Zeng X; Xiao S
Genomics; 2023 Mar; 115(2):110554. PubMed ID: 36587749
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
Konaté MM; Li MC; McShane LM; Zhao Y
Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical evaluation of forkhead box A1 and EphA5 markers in serous ovarian carcinomas, and their impact on the clinical outcome of patients.
Abouhashem N; Harb O; Elwan A; Zaitoun M; Saraya Y
Pol J Pathol; 2022; 73(2):120-133. PubMed ID: 36345952
[TBL] [Abstract] [Full Text] [Related]
7. Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association.
El-Sheikh NM; Abulsoud AI; Wasfey EF; Hamdy NM
Pathol Res Pract; 2022 Dec; 240():154183. PubMed ID: 36327824
[TBL] [Abstract] [Full Text] [Related]
8. A Systematic Pan-cancer Analysis of YY1 Aberrations and their Relationship with clinical outcome, Tumor Microenvironment, and Therapeutic Targets.
Fu X; Ji F; He Q; Qiu X
J Immunol Res; 2022; 2022():5826741. PubMed ID: 35791393
[TBL] [Abstract] [Full Text] [Related]
9. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
[TBL] [Abstract] [Full Text] [Related]
10. Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers
Khalique S; Nash S; Natrajan R
J Pathol; 2022 Sep; 258(1):1-3. PubMed ID: 35647895
[TBL] [Abstract] [Full Text] [Related]
11. ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer.
Hua T; Wang RM; Zhang XC; Zhao BB; Fan SB; Liu DX; Wang W
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34793589
[TBL] [Abstract] [Full Text] [Related]
12. Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer.
Li DF; Tulahong A; Uddin MN; Zhao H; Zhang H
Math Biosci Eng; 2021 Jul; 18(5):6527-6551. PubMed ID: 34517544
[TBL] [Abstract] [Full Text] [Related]
13. A Critical Assessment of the Association between HLA-G Expression by Carcinomas and clinical outcome.
van de Water RB; Krijgsman D; Houvast RD; Vahrmeijer AL; Kuppen PJK
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361031
[TBL] [Abstract] [Full Text] [Related]
14. The cyclin-dependent kinase inhibitor AT7519 augments cisplatin's efficacy in ovarian cancer via multiple oncogenic signaling pathways.
Wang L; Chen Y; Li H; Xu Q; Liu R
Fundam Clin Pharmacol; 2022 Feb; 36(1):81-88. PubMed ID: 34212421
[TBL] [Abstract] [Full Text] [Related]
15. Role of ZBTB7A zinc finger in tumorigenesis and metastasis.
Singh AK; Verma S; Kushwaha PP; Prajapati KS; Shuaib M; Kumar S; Gupta S
Mol Biol Rep; 2021 May; 48(5):4703-4719. PubMed ID: 34014468
[TBL] [Abstract] [Full Text] [Related]
16. The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models.
Maser IP; Hoves S; Bayer C; Heidkamp G; Nimmerjahn F; Eckmann J; Ries CH
Front Immunol; 2020; 11():2082. PubMed ID: 33013879
[TBL] [Abstract] [Full Text] [Related]
17. Inflammatory state of lymphatic vessels and miRNA profiles associated with relapse in ovarian cancer patients.
Johnson SC; Chakraborty S; Drosou A; Cunnea P; Tzovaras D; Nixon K; Zawieja DC; Muthuchamy M; Fotopoulou C; Moore JE
PLoS One; 2020; 15(7):e0230092. PubMed ID: 32716937
[TBL] [Abstract] [Full Text] [Related]
18. Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma.
Matsushita H; Hasegawa K; Oda K; Yamamoto S; Asada K; Karasaki T; Yabuno A; Nishijima A; Nejo T; Kobayashi Y; Sato S; Ikeda Y; Miyai M; Takahashi Y; Yamaguchi R; Fujiwara K; Aburatani H; Kakimi K
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461346
[TBL] [Abstract] [Full Text] [Related]
19. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.
Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L
J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842
[TBL] [Abstract] [Full Text] [Related]
20. Genome-wide DNA copy number profiling and bioinformatics analysis of ovarian cancer reveals key genes and pathways associated with distinct invasive/migratory capabilities.
Liu G; Ruan G; Huang M; Chen L; Sun P
Aging (Albany NY); 2020 Jan; 12(1):178-192. PubMed ID: 31895688
[TBL] [Abstract] [Full Text] [Related]
[Next]